Literature DB >> 31625438

Does restless legs syndrome impact cognitive function via sleep quality in adults with Parkinson's disease?

Katie L Cederberg1, Elizabeth B Brinkley2, Natalya Belotserkovkaya3, Raima A Memon2, Robert W Motl1, Amy W Amara2.   

Abstract

Purpose: Restless legs syndrome (RLS) is a sleep disorder that results in sleep dysfunction. Sleep disruption can have profound negative consequences in adults with Parkinson's disease (PD), potentially including cognitive dysfunction. This study examined the relationships among RLS, cognition, and sleep quality in persons with PD.Materials and methods: Participants (N = 79) with idiopathic PD completed six questionnaires evaluating RLS, sleep quality, daytime sleepiness, global cognitive function, sleep apnea risk, and depression. Participants were further examined for body mass index composition and motor symptom severity (MDS-UPDRS Part III).
Results: Persons with RLS (n = 25) had significantly worse cognitive function (p = 0.035, d = -0.56) and sleep quality (p < 0.0001, d = -1.19), and more daytime sleepiness (p = 0.009, d = 0.67) than those without RLS (n = 54). Cognitive function was not significantly correlated with sleep quality (rs = 0.113) or daytime sleepiness (rs = -0.001). The association between RLS and cognition was not attenuated by controlling for sleep quality or daytime sleepiness.Conclusions: This study is unique as it is the first to consider the possibility that RLS in PD may be associated with cognitive deficits through a pathway involving sleep quality. Persons with RLS and PD have greater deficits in both sleep quality and cognitive function than individuals without RLS; however, cognitive dysfunction among those with PD and RLS in this sample is not accounted for by sleep quality.

Entities:  

Keywords:  Parkinson’s disease; Restless legs syndrome; cognitive function; daytime sleepiness; sleep quality

Mesh:

Year:  2019        PMID: 31625438      PMCID: PMC7101254          DOI: 10.1080/00207454.2019.1681423

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  43 in total

1.  The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease.

Authors:  K R Chaudhuri; S Pal; A DiMarco; C Whately-Smith; K Bridgman; R Mathew; F R Pezzela; A Forbes; B Högl; C Trenkwalder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Increased risk of leg motor restlessness but not RLS in early Parkinson disease.

Authors:  M D Gjerstad; O B Tysnes; J P Larsen
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

3.  Prevalence and clinical profile of restless legs syndrome in Parkinson's disease.

Authors:  Dagmar Verbaan; Stephanie M van Rooden; Jacobus J van Hilten; Roselyne M Rijsman
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

4.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

5.  The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease.

Authors:  Matthew Menza; Roseanne Defronzo Dobkin; Humberto Marin; Margery H Mark; Michael Gara; Karina Bienfait; Allison Dicke; Alex Kusnekov
Journal:  Psychosomatics       Date:  2010 Nov-Dec       Impact factor: 2.386

6.  The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease.

Authors:  A F Leentjens; F R Verhey; R Lousberg; H Spitsbergen; F W Wilmink
Journal:  Int J Geriatr Psychiatry       Date:  2000-07       Impact factor: 3.485

7.  The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

Authors:  J C Dalrymple-Alford; M R MacAskill; C T Nakas; L Livingston; C Graham; G P Crucian; T R Melzer; J Kirwan; R Keenan; S Wells; R J Porter; R Watts; T J Anderson
Journal:  Neurology       Date:  2010-11-09       Impact factor: 9.910

Review 8.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

9.  Restless legs syndrome in Parkinson's disease.

Authors:  Juan C Gómez-Esteban; Juan J Zarranz; Beatriz Tijero; Fernando Velasco; Joseba Barcena; Idoia Rouco; Elena Lezcano; María C Lachen; Amaia Jauregui; Amaia Ugarte
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

10.  Prevalence and profile of Restless Legs Syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control study.

Authors:  Ketaki Bhalsing; K Suresh; Uday B Muthane; Pramod Kr Pal
Journal:  Parkinsonism Relat Disord       Date:  2013-01-18       Impact factor: 4.891

View more
  5 in total

1.  Restless legs syndrome, sleep quality, and perceived cognitive impairment in adults with multiple sclerosis.

Authors:  Katie L J Cederberg; Brenda Jeng; Jeffer E Sasaki; Robert W Motl
Journal:  Mult Scler Relat Disord       Date:  2020-05-18       Impact factor: 4.339

Review 2.  Sleep Disorders and Cognitive Dysfunctions in Parkinson's Disease: A Meta-Analytic Study.

Authors:  Gianpaolo Maggi; Luigi Trojano; Paolo Barone; Gabriella Santangelo
Journal:  Neuropsychol Rev       Date:  2021-03-29       Impact factor: 7.444

3.  The cognitive impact of guard shifts in physicians: a before-after study.

Authors:  Cristina Benítez-Provedo; Blanca Talavera; David García-Azorín; Alberto Marcos-Dolado
Journal:  Neurol Sci       Date:  2021-08-18       Impact factor: 3.307

Review 4.  Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease.

Authors:  Reyisha Taximaimaiti; Xingguang Luo; Xiao-Ping Wang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

5.  Characteristics of Objective Sleep and Its Related Risk Factors Among Parkinson's Disease Patients With and Without Restless Legs Syndrome.

Authors:  Shuyu Sun; Xianchao Zhao; Jiafeng Ren; Jinxiang Cheng; Junying Zhou; Changjun Su
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.